Bionic Vision Technologies raised $18 million for development and commercialization of its device to restore vision to the blind.
CardioFocus raised $20 million, which will boost the commercialization of its endoscopic ablation system for the treatment of a fib.
It’s a critical tradeoff for life. Our bodies use sugar and fat from the food we consume to produce energy in our cells’ mitochondria, the internal powerhouses…
Cancer blood test business Biocept has priced shares and warrants worth an anticipated $9.3 million.
Theranos’ board approved a deal to offer more shares to investors who promise not to sue the company, sources told The Wall Street Journal.
Ivenix reeled in the first tranche of $50 million in equity, which will support its bid for FDA clearance of its next-gen infusion pump.
AliveCor is launching a new platform to help physicians manage reports from its smartphone ECG recorder.
RenalGuard Solutions raised $14.5 million in a Series A round. The funds will support the pivotal trial of a device that protects the kidneys.
Johnson & Johnson is planning to close a surgical suture production plant, potentially putting 400 people out of work.
Vertiflex closed a $40 million financing round, which will fund the commercial expansion of its minimally invasive spinal stenosis implant in the U.S.
Velano Vascular raised $17 million in financing, which it will put toward scaling and commercializing its line of vascular access devices.